

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 5.35411898 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 5.28534925 |
| 3 | maturation of SSU-rRNA (GO:0030490) | 5.07542773 |
| 4 | viral transcription (GO:0019083) | 4.94952994 |
| 5 | ribosomal small subunit biogenesis (GO:0042274) | 4.93334852 |
| 6 | translational termination (GO:0006415) | 4.84956050 |
| 7 | regulation of RIG-I signaling pathway (GO:0039535) | 4.83032196 |
| 8 | ribosomal large subunit biogenesis (GO:0042273) | 4.81366576 |
| 9 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.52839149 |
| 10 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.38866833 |
| 11 | rRNA methylation (GO:0031167) | 4.37190978 |
| 12 | translational elongation (GO:0006414) | 4.33551807 |
| 13 | cotranslational protein targeting to membrane (GO:0006613) | 4.33237684 |
| 14 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.29175989 |
| 15 | protein targeting to ER (GO:0045047) | 4.28640766 |
| 16 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.20399587 |
| 17 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.19179102 |
| 18 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.13591001 |
| 19 | translational initiation (GO:0006413) | 4.12647151 |
| 20 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.12365870 |
| 21 | negative regulation of ligase activity (GO:0051352) | 4.10528088 |
| 22 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.10528088 |
| 23 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.08938798 |
| 24 | protein localization to endoplasmic reticulum (GO:0070972) | 4.07964867 |
| 25 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.05126116 |
| 26 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.04321436 |
| 27 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.03674013 |
| 28 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.03674013 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 4.02620545 |
| 30 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.01986358 |
| 31 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.00604154 |
| 32 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.00604154 |
| 33 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.00604154 |
| 34 | positive regulation of hormone biosynthetic process (GO:0046886) | 4.00235464 |
| 35 | DNA deamination (GO:0045006) | 3.96355585 |
| 36 | formation of translation preinitiation complex (GO:0001731) | 3.96207853 |
| 37 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.90694039 |
| 38 | termination of RNA polymerase III transcription (GO:0006386) | 3.90694039 |
| 39 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.90405762 |
| 40 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.90405762 |
| 41 | viral life cycle (GO:0019058) | 3.88877862 |
| 42 | cellular protein complex disassembly (GO:0043624) | 3.87763257 |
| 43 | translation (GO:0006412) | 3.87657741 |
| 44 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.87050209 |
| 45 | DNA strand elongation (GO:0022616) | 3.85213296 |
| 46 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.85148620 |
| 47 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.83991511 |
| 48 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.78988634 |
| 49 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.78611695 |
| 50 | mRNA cleavage (GO:0006379) | 3.74538271 |
| 51 | cullin deneddylation (GO:0010388) | 3.71753557 |
| 52 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.70902753 |
| 53 | ribosome assembly (GO:0042255) | 3.70497425 |
| 54 | 7-methylguanosine mRNA capping (GO:0006370) | 3.69366267 |
| 55 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.66093644 |
| 56 | protein deneddylation (GO:0000338) | 3.66029466 |
| 57 | telomere maintenance via recombination (GO:0000722) | 3.59057140 |
| 58 | 7-methylguanosine RNA capping (GO:0009452) | 3.58657038 |
| 59 | RNA capping (GO:0036260) | 3.58657038 |
| 60 | positive regulation of ligase activity (GO:0051351) | 3.54977440 |
| 61 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.54858622 |
| 62 | purine nucleobase biosynthetic process (GO:0009113) | 3.52770148 |
| 63 | spliceosomal snRNP assembly (GO:0000387) | 3.49392397 |
| 64 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.49359678 |
| 65 | DNA replication checkpoint (GO:0000076) | 3.48133622 |
| 66 | nucleobase biosynthetic process (GO:0046112) | 3.46354945 |
| 67 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.44880871 |
| 68 | ATP synthesis coupled proton transport (GO:0015986) | 3.44880871 |
| 69 | protein complex biogenesis (GO:0070271) | 3.43233761 |
| 70 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.42158929 |
| 71 | rRNA processing (GO:0006364) | 3.40906234 |
| 72 | COPI coating of Golgi vesicle (GO:0048205) | 3.40711670 |
| 73 | Golgi transport vesicle coating (GO:0048200) | 3.40711670 |
| 74 | positive regulation of protein sumoylation (GO:0033235) | 3.40425026 |
| 75 | DNA replication initiation (GO:0006270) | 3.36902290 |
| 76 | protein complex disassembly (GO:0043241) | 3.33809182 |
| 77 | positive regulation of cell cycle arrest (GO:0071158) | 3.31192227 |
| 78 | cellular component biogenesis (GO:0044085) | 3.26556798 |
| 79 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.26230698 |
| 80 | mitotic recombination (GO:0006312) | 3.25401355 |
| 81 | rRNA metabolic process (GO:0016072) | 3.25204144 |
| 82 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.25024536 |
| 83 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.24154337 |
| 84 | maturation of 5.8S rRNA (GO:0000460) | 3.23592894 |
| 85 | CENP-A containing nucleosome assembly (GO:0034080) | 3.23514744 |
| 86 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.23233577 |
| 87 | tRNA aminoacylation for protein translation (GO:0006418) | 3.23085332 |
| 88 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.21430880 |
| 89 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.21430880 |
| 90 | NADH dehydrogenase complex assembly (GO:0010257) | 3.21430880 |
| 91 | respiratory electron transport chain (GO:0022904) | 3.21380401 |
| 92 | protein neddylation (GO:0045116) | 3.21167677 |
| 93 | macromolecular complex disassembly (GO:0032984) | 3.21023502 |
| 94 | regulation of mitochondrial translation (GO:0070129) | 3.19246167 |
| 95 | rRNA modification (GO:0000154) | 3.19124219 |
| 96 | tRNA aminoacylation (GO:0043039) | 3.17415379 |
| 97 | amino acid activation (GO:0043038) | 3.17415379 |
| 98 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.16073564 |
| 99 | cell cycle G1/S phase transition (GO:0044843) | 3.16073564 |
| 100 | protein localization to mitochondrion (GO:0070585) | 3.15515760 |
| 101 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.15300361 |
| 102 | termination of RNA polymerase I transcription (GO:0006363) | 3.14660916 |
| 103 | establishment of protein localization to mitochondrion (GO:0072655) | 3.14205055 |
| 104 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.13100504 |
| 105 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.12912509 |
| 106 | chromatin remodeling at centromere (GO:0031055) | 3.12582631 |
| 107 | regulation of ligase activity (GO:0051340) | 3.11960631 |
| 108 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.11943500 |
| 109 | electron transport chain (GO:0022900) | 3.11663519 |
| 110 | GDP-mannose metabolic process (GO:0019673) | 3.10426717 |
| 111 | pseudouridine synthesis (GO:0001522) | 3.08646353 |
| 112 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.07751364 |
| 113 | protein maturation by protein folding (GO:0022417) | 3.05582578 |
| 114 | spliceosomal complex assembly (GO:0000245) | 3.04677800 |
| 115 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.04489056 |
| 116 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.04489056 |
| 117 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.04338789 |
| 118 | telomere maintenance via telomere lengthening (GO:0010833) | 3.04072964 |
| 119 | ribosome biogenesis (GO:0042254) | 3.03278878 |
| 120 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.00109742 |
| 121 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.99723868 |
| 122 | mitotic metaphase plate congression (GO:0007080) | 2.99413081 |
| 123 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.99304690 |
| 124 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.99177629 |
| 125 | DNA damage response, detection of DNA damage (GO:0042769) | 2.98285805 |
| 126 | transcription from RNA polymerase I promoter (GO:0006360) | 2.96704108 |
| 127 | protein targeting to mitochondrion (GO:0006626) | 2.96156458 |
| 128 | regulation of protein sumoylation (GO:0033233) | 2.95316642 |
| 129 | positive regulation of glycolytic process (GO:0045821) | 2.95060634 |
| 130 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.94122774 |
| 131 | chaperone-mediated protein transport (GO:0072321) | 2.92295738 |
| 132 | positive regulation of fibroblast migration (GO:0010763) | 2.91887814 |
| 133 | regulation of translational termination (GO:0006449) | 2.89627684 |
| 134 | respiratory chain complex IV assembly (GO:0008535) | 2.88679277 |
| 135 | COPII vesicle coating (GO:0048208) | 2.88100482 |
| 136 | positive regulation of hormone metabolic process (GO:0032352) | 2.81125744 |
| 137 | regulation of cellular amine metabolic process (GO:0033238) | 2.77350696 |
| 138 | regulation of translation in response to stress (GO:0043555) | 2.77097180 |
| 139 | GMP metabolic process (GO:0046037) | 2.76137331 |
| 140 | oxidative phosphorylation (GO:0006119) | 2.72839042 |
| 141 | tetrahydrofolate metabolic process (GO:0046653) | 2.71873855 |
| 142 | AMP metabolic process (GO:0046033) | 2.71187340 |
| 143 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.69584457 |
| 144 | cellular response to nicotine (GO:0071316) | 2.68533687 |
| 145 | cellular response to arsenic-containing substance (GO:0071243) | 2.68396665 |
| 146 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.64723729 |
| 147 | histone mRNA metabolic process (GO:0008334) | 2.63343407 |
| 148 | peptidyl-histidine modification (GO:0018202) | 2.61691194 |
| 149 | response to testosterone (GO:0033574) | 2.61208521 |
| 150 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.61012536 |
| 151 | C-terminal protein lipidation (GO:0006501) | 2.60413057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.74084214 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.51209103 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.25699334 |
| 4 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.02161964 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.81491681 |
| 6 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.77045413 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.72151147 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.39905127 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.37130192 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.35811736 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.04282470 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.83986952 |
| 13 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.81467792 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.78492197 |
| 15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.78312242 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.76977343 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.74114384 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.70356903 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.66321058 |
| 20 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.57998942 |
| 21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.56996794 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.56829902 |
| 23 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.56047874 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.53092462 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.48306854 |
| 26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.47966084 |
| 27 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.33084735 |
| 28 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.28835382 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.19462356 |
| 30 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.11403893 |
| 31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.08071840 |
| 32 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.05471129 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.03155079 |
| 34 | * TTF2_22483619_ChIP-Seq_HELA_Human | 2.02941982 |
| 35 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.01261062 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92571199 |
| 37 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.92371019 |
| 38 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.88113730 |
| 39 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.84702590 |
| 40 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77277171 |
| 41 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.74149806 |
| 42 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.73389254 |
| 43 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.72270978 |
| 44 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.64874007 |
| 45 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.61109460 |
| 46 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.60475948 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59457883 |
| 48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.58590479 |
| 49 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.58529410 |
| 50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54972912 |
| 51 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.50600169 |
| 52 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.49266465 |
| 53 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43773812 |
| 54 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40198431 |
| 55 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.39170842 |
| 56 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.38998646 |
| 57 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.38663454 |
| 58 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.38584194 |
| 59 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.38146796 |
| 60 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.37977148 |
| 61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.33624269 |
| 62 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.31962434 |
| 63 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.28539930 |
| 64 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.27554560 |
| 65 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.25454355 |
| 66 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24989034 |
| 67 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24401654 |
| 68 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.23629129 |
| 69 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.22512797 |
| 70 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.21659252 |
| 71 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20271004 |
| 72 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.19030058 |
| 73 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.17090960 |
| 74 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.14507613 |
| 75 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.13684532 |
| 76 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08612176 |
| 77 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.04217223 |
| 78 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03730929 |
| 79 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02729132 |
| 80 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.00147277 |
| 81 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99536069 |
| 82 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.98472587 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98126737 |
| 84 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98020588 |
| 85 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97391395 |
| 86 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.96850963 |
| 87 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.96717379 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96677255 |
| 89 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.95997039 |
| 90 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.95228348 |
| 91 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.95083082 |
| 92 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.92348742 |
| 93 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.92080239 |
| 94 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.91923362 |
| 95 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.89545117 |
| 96 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.88687436 |
| 97 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.86993283 |
| 98 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.86577519 |
| 99 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.83815138 |
| 100 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.83497365 |
| 101 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.82363949 |
| 102 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.81315521 |
| 103 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.80305758 |
| 104 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.78383293 |
| 105 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.77338403 |
| 106 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77292447 |
| 107 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.77091944 |
| 108 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.75116996 |
| 109 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.73680109 |
| 110 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.72575390 |
| 111 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.72373768 |
| 112 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.71575023 |
| 113 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.71347226 |
| 114 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.68905958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.53236953 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.93628853 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.44459926 |
| 4 | MP0003077_abnormal_cell_cycle | 3.29722185 |
| 5 | MP0009379_abnormal_foot_pigmentation | 3.27644154 |
| 6 | MP0003111_abnormal_nucleus_morphology | 3.19156491 |
| 7 | MP0008058_abnormal_DNA_repair | 3.17429891 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.14520241 |
| 9 | MP0008932_abnormal_embryonic_tissue | 2.77088993 |
| 10 | MP0008057_abnormal_DNA_replication | 2.69542179 |
| 11 | MP0003950_abnormal_plasma_membrane | 2.58497019 |
| 12 | MP0003186_abnormal_redox_activity | 2.48697540 |
| 13 | MP0003718_maternal_effect | 2.40053606 |
| 14 | MP0005410_abnormal_fertilization | 2.28854769 |
| 15 | MP0003786_premature_aging | 2.16782864 |
| 16 | MP0003123_paternal_imprinting | 2.07986725 |
| 17 | MP0009697_abnormal_copulation | 2.06303198 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.01818261 |
| 19 | MP0008007_abnormal_cellular_replicative | 2.00957799 |
| 20 | MP0003315_abnormal_perineum_morphology | 1.92816264 |
| 21 | MP0000343_altered_response_to | 1.84614399 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 1.81075370 |
| 23 | MP0005332_abnormal_amino_acid | 1.80502942 |
| 24 | MP0001764_abnormal_homeostasis | 1.77896570 |
| 25 | MP0002132_abnormal_respiratory_system | 1.76060018 |
| 26 | MP0002796_impaired_skin_barrier | 1.75160416 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.74232914 |
| 28 | MP0001730_embryonic_growth_arrest | 1.71290488 |
| 29 | MP0001881_abnormal_mammary_gland | 1.67182368 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.66519846 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.53829222 |
| 32 | MP0003303_peritoneal_inflammation | 1.50784373 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.49790988 |
| 34 | MP0005408_hypopigmentation | 1.44831920 |
| 35 | MP0005083_abnormal_biliary_tract | 1.39924323 |
| 36 | MP0006082_CNS_inflammation | 1.39252869 |
| 37 | MP0010234_abnormal_vibrissa_follicle | 1.39176540 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.38999949 |
| 39 | MP0009785_altered_susceptibility_to | 1.37141314 |
| 40 | MP0000749_muscle_degeneration | 1.36543251 |
| 41 | MP0000313_abnormal_cell_death | 1.34874295 |
| 42 | MP0006035_abnormal_mitochondrial_morpho | 1.33774637 |
| 43 | MP0000350_abnormal_cell_proliferation | 1.32631492 |
| 44 | MP0003436_decreased_susceptibility_to | 1.32021311 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.31916177 |
| 46 | MP0008260_abnormal_autophagy | 1.28752643 |
| 47 | MP0008995_early_reproductive_senescence | 1.26768976 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.23774575 |
| 49 | MP0000490_abnormal_crypts_of | 1.23327245 |
| 50 | MP0005501_abnormal_skin_physiology | 1.22329822 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.19497186 |
| 52 | MP0001853_heart_inflammation | 1.19432250 |
| 53 | MP0005451_abnormal_body_composition | 1.18497007 |
| 54 | MP0002019_abnormal_tumor_incidence | 1.18440907 |
| 55 | MP0001727_abnormal_embryo_implantation | 1.16132418 |
| 56 | MP0000372_irregular_coat_pigmentation | 1.15762189 |
| 57 | MP0001243_abnormal_dermal_layer | 1.15408392 |
| 58 | MP0004782_abnormal_surfactant_physiolog | 1.14802958 |
| 59 | MP0005360_urolithiasis | 1.14153084 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.13532128 |
| 61 | MP0002938_white_spotting | 1.13476569 |
| 62 | MP0008877_abnormal_DNA_methylation | 1.11110662 |
| 63 | MP0005025_abnormal_response_to | 1.10425489 |
| 64 | MP0005319_abnormal_enzyme/_coenzyme | 1.09950679 |
| 65 | MP0001661_extended_life_span | 1.09389866 |
| 66 | MP0000609_abnormal_liver_physiology | 1.09223489 |
| 67 | MP0001529_abnormal_vocalization | 1.08691867 |
| 68 | MP0002139_abnormal_hepatobiliary_system | 1.08511781 |
| 69 | MP0005085_abnormal_gallbladder_physiolo | 1.07594278 |
| 70 | MP0001697_abnormal_embryo_size | 1.07190867 |
| 71 | MP0010307_abnormal_tumor_latency | 1.06830905 |
| 72 | MP0002163_abnormal_gland_morphology | 1.06196189 |
| 73 | MP0003195_calcinosis | 1.04827675 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 1.04813168 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 1.04715770 |
| 76 | MP0005379_endocrine/exocrine_gland_phen | 1.03618597 |
| 77 | MP0000015_abnormal_ear_pigmentation | 1.02888647 |
| 78 | MP0002398_abnormal_bone_marrow | 1.02434382 |
| 79 | MP0002080_prenatal_lethality | 1.02381803 |
| 80 | MP0005395_other_phenotype | 1.02167443 |
| 81 | MP0000689_abnormal_spleen_morphology | 1.02129500 |
| 82 | MP0003763_abnormal_thymus_physiology | 1.01785283 |
| 83 | MP0010030_abnormal_orbit_morphology | 1.00073912 |
| 84 | MP0002090_abnormal_vision | 0.99673920 |
| 85 | MP0005671_abnormal_response_to | 0.99619165 |
| 86 | MP0002429_abnormal_blood_cell | 0.99588339 |
| 87 | MP0003011_delayed_dark_adaptation | 0.99389053 |
| 88 | MP0005000_abnormal_immune_tolerance | 0.99335858 |
| 89 | MP0000358_abnormal_cell_content/ | 0.98871393 |
| 90 | MP0001800_abnormal_humoral_immune | 0.98540718 |
| 91 | MP0006276_abnormal_autonomic_nervous | 0.97544612 |
| 92 | MP0000685_abnormal_immune_system | 0.97160810 |
| 93 | MP0003221_abnormal_cardiomyocyte_apopto | 0.96700250 |
| 94 | MP0004147_increased_porphyrin_level | 0.96490027 |
| 95 | MP0002452_abnormal_antigen_presenting | 0.96487284 |
| 96 | MP0002722_abnormal_immune_system | 0.95664693 |
| 97 | MP0002210_abnormal_sex_determination | 0.95059089 |
| 98 | MP0001790_abnormal_immune_system | 0.94374932 |
| 99 | MP0005387_immune_system_phenotype | 0.94374932 |
| 100 | MP0002723_abnormal_immune_serum | 0.93988938 |
| 101 | MP0005084_abnormal_gallbladder_morpholo | 0.92511688 |
| 102 | MP0008875_abnormal_xenobiotic_pharmacok | 0.92107643 |
| 103 | MP0001819_abnormal_immune_cell | 0.91307119 |
| 104 | MP0002420_abnormal_adaptive_immunity | 0.91207979 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 0.89957138 |
| 106 | MP0003567_abnormal_fetal_cardiomyocyte | 0.88582103 |
| 107 | MP0009780_abnormal_chondrocyte_physiolo | 0.88352116 |
| 108 | MP0005380_embryogenesis_phenotype | 0.87254826 |
| 109 | MP0001672_abnormal_embryogenesis/_devel | 0.87254826 |
| 110 | MP0000716_abnormal_immune_system | 0.86636773 |
| 111 | MP0001905_abnormal_dopamine_level | 0.85999929 |
| 112 | MP0005389_reproductive_system_phenotype | 0.85794536 |
| 113 | MP0008469_abnormal_protein_level | 0.84888076 |
| 114 | MP0004272_abnormal_basement_membrane | 0.84374808 |
| 115 | MP0002419_abnormal_innate_immunity | 0.84221857 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84121106 |
| 117 | MP0009763_increased_sensitivity_to | 0.82603548 |
| 118 | MP0002160_abnormal_reproductive_system | 0.82512131 |
| 119 | MP0001216_abnormal_epidermal_layer | 0.81517177 |
| 120 | MP0003941_abnormal_skin_development | 0.80869572 |
| 121 | MP0008789_abnormal_olfactory_epithelium | 0.80839990 |
| 122 | MP0001119_abnormal_female_reproductive | 0.80228682 |
| 123 | MP0005636_abnormal_mineral_homeostasis | 0.79946416 |
| 124 | MP0000858_altered_metastatic_potential | 0.79065327 |
| 125 | MP0003724_increased_susceptibility_to | 0.78415046 |
| 126 | MP0001919_abnormal_reproductive_system | 0.77958807 |
| 127 | MP0002295_abnormal_pulmonary_circulatio | 0.77829679 |
| 128 | MP0008775_abnormal_heart_ventricle | 0.77172252 |
| 129 | MP0001542_abnormal_bone_strength | 0.76621399 |
| 130 | MP0001145_abnormal_male_reproductive | 0.76064462 |
| 131 | MP0003984_embryonic_growth_retardation | 0.76027417 |
| 132 | MP0002405_respiratory_system_inflammati | 0.74835798 |
| 133 | MP0009840_abnormal_foam_cell | 0.74614137 |
| 134 | MP0002088_abnormal_embryonic_growth/wei | 0.74597583 |
| 135 | MP0001845_abnormal_inflammatory_respons | 0.74382944 |
| 136 | MP0002060_abnormal_skin_morphology | 0.73810459 |
| 137 | MP0005330_cardiomyopathy | 0.73694284 |
| 138 | MP0005310_abnormal_salivary_gland | 0.73022654 |
| 139 | MP0000627_abnormal_mammary_gland | 0.72818589 |
| 140 | MP0002970_abnormal_white_adipose | 0.70708345 |
| 141 | MP0005376_homeostasis/metabolism_phenot | 0.70224281 |
| 142 | MP0005164_abnormal_response_to | 0.69801329 |
| 143 | MP0003448_altered_tumor_morphology | 0.69671722 |
| 144 | MP0004381_abnormal_hair_follicle | 0.69234373 |
| 145 | MP0000703_abnormal_thymus_morphology | 0.68933631 |
| 146 | MP0002751_abnormal_autonomic_nervous | 0.68789390 |
| 147 | MP0001929_abnormal_gametogenesis | 0.68122771 |
| 148 | MP0005166_decreased_susceptibility_to | 0.68106419 |
| 149 | MP0002277_abnormal_respiratory_mucosa | 0.67966228 |
| 150 | MP0000653_abnormal_sex_gland | 0.66988458 |
| 151 | MP0006054_spinal_hemorrhage | 0.66820691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.77414029 |
| 2 | Reticulocytopenia (HP:0001896) | 4.48136833 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 4.41331635 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.19325364 |
| 5 | Birth length less than 3rd percentile (HP:0003561) | 4.10821800 |
| 6 | Macrocytic anemia (HP:0001972) | 3.99521298 |
| 7 | Mitochondrial inheritance (HP:0001427) | 3.90044572 |
| 8 | Increased hepatocellular lipid droplets (HP:0006565) | 3.72750842 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.66126064 |
| 10 | Increased CSF lactate (HP:0002490) | 3.60142569 |
| 11 | Breast hypoplasia (HP:0003187) | 3.56734005 |
| 12 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.51875156 |
| 13 | Hepatocellular necrosis (HP:0001404) | 3.51074523 |
| 14 | Increased serum pyruvate (HP:0003542) | 3.49859937 |
| 15 | Abnormality of glycolysis (HP:0004366) | 3.49859937 |
| 16 | Acute encephalopathy (HP:0006846) | 3.49501568 |
| 17 | Oral leukoplakia (HP:0002745) | 3.49453458 |
| 18 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.44891450 |
| 19 | Abnormal gallbladder physiology (HP:0012438) | 3.41225674 |
| 20 | Cholecystitis (HP:0001082) | 3.41225674 |
| 21 | 3-Methylglutaconic aciduria (HP:0003535) | 3.37250562 |
| 22 | Lipid accumulation in hepatocytes (HP:0006561) | 3.36438748 |
| 23 | Hepatic necrosis (HP:0002605) | 3.31879355 |
| 24 | Upper limb muscle weakness (HP:0003484) | 3.23516172 |
| 25 | Progressive macrocephaly (HP:0004481) | 3.22059277 |
| 26 | Increased serum lactate (HP:0002151) | 3.20829387 |
| 27 | Pallor (HP:0000980) | 3.20249831 |
| 28 | Exertional dyspnea (HP:0002875) | 3.19262589 |
| 29 | Renal Fanconi syndrome (HP:0001994) | 3.15583243 |
| 30 | Hypokinesia (HP:0002375) | 3.10460958 |
| 31 | Abnormal protein glycosylation (HP:0012346) | 3.07985707 |
| 32 | Abnormal glycosylation (HP:0012345) | 3.07985707 |
| 33 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.07985707 |
| 34 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.07985707 |
| 35 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.06166119 |
| 36 | Cerebral hypomyelination (HP:0006808) | 3.04809412 |
| 37 | Orthostatic hypotension (HP:0001278) | 3.00196805 |
| 38 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.94446898 |
| 39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.94446898 |
| 40 | Cerebral edema (HP:0002181) | 2.85110198 |
| 41 | Generalized aminoaciduria (HP:0002909) | 2.78526776 |
| 42 | Rough bone trabeculation (HP:0100670) | 2.74060016 |
| 43 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.73678614 |
| 44 | Aplastic anemia (HP:0001915) | 2.68522588 |
| 45 | Carpal bone hypoplasia (HP:0001498) | 2.60187456 |
| 46 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.56555889 |
| 47 | Abnormality of alanine metabolism (HP:0010916) | 2.56555889 |
| 48 | Hyperalaninemia (HP:0003348) | 2.56555889 |
| 49 | Exercise intolerance (HP:0003546) | 2.52460577 |
| 50 | Microretrognathia (HP:0000308) | 2.50677713 |
| 51 | Multiple enchondromatosis (HP:0005701) | 2.46603966 |
| 52 | Respiratory failure (HP:0002878) | 2.45440773 |
| 53 | Respiratory difficulties (HP:0002880) | 2.45286833 |
| 54 | Hypophosphatemic rickets (HP:0004912) | 2.42895462 |
| 55 | Type I transferrin isoform profile (HP:0003642) | 2.42712666 |
| 56 | Poor head control (HP:0002421) | 2.41891629 |
| 57 | Lactic acidosis (HP:0003128) | 2.41071198 |
| 58 | Nausea (HP:0002018) | 2.40465302 |
| 59 | Conjunctival hamartoma (HP:0100780) | 2.39648859 |
| 60 | Abnormality of the anterior horn cell (HP:0006802) | 2.39594821 |
| 61 | Degeneration of anterior horn cells (HP:0002398) | 2.39594821 |
| 62 | Microvesicular hepatic steatosis (HP:0001414) | 2.35886386 |
| 63 | Secondary amenorrhea (HP:0000869) | 2.32263332 |
| 64 | Ragged-red muscle fibers (HP:0003200) | 2.30875593 |
| 65 | Cortical visual impairment (HP:0100704) | 2.29447202 |
| 66 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.27130575 |
| 67 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.26424608 |
| 68 | Increased intramyocellular lipid droplets (HP:0012240) | 2.26213442 |
| 69 | Amniotic constriction ring (HP:0009775) | 2.25969582 |
| 70 | Abnormality of placental membranes (HP:0011409) | 2.25969582 |
| 71 | Sensory axonal neuropathy (HP:0003390) | 2.25134440 |
| 72 | Emotional lability (HP:0000712) | 2.23873633 |
| 73 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.22126867 |
| 74 | Hyperthyroidism (HP:0000836) | 2.21425435 |
| 75 | Abnormality of methionine metabolism (HP:0010901) | 2.20674269 |
| 76 | Tetraparesis (HP:0002273) | 2.20527145 |
| 77 | 11 pairs of ribs (HP:0000878) | 2.17331317 |
| 78 | Abnormal trabecular bone morphology (HP:0100671) | 2.16755262 |
| 79 | Abnormality of the preputium (HP:0100587) | 2.15680103 |
| 80 | CNS demyelination (HP:0007305) | 2.12542862 |
| 81 | Absent thumb (HP:0009777) | 2.12528577 |
| 82 | Horseshoe kidney (HP:0000085) | 2.11156015 |
| 83 | Patellar aplasia (HP:0006443) | 2.11036022 |
| 84 | Meckel diverticulum (HP:0002245) | 2.10423883 |
| 85 | Leukodystrophy (HP:0002415) | 2.09673591 |
| 86 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.09151154 |
| 87 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08014549 |
| 88 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08014549 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08014549 |
| 90 | Testicular atrophy (HP:0000029) | 2.06452934 |
| 91 | Agnosia (HP:0010524) | 2.06379123 |
| 92 | Prolonged neonatal jaundice (HP:0006579) | 2.06269665 |
| 93 | Severe visual impairment (HP:0001141) | 2.04746855 |
| 94 | Cellular immunodeficiency (HP:0005374) | 2.04161044 |
| 95 | Megaloblastic anemia (HP:0001889) | 2.04032415 |
| 96 | Vacuolated lymphocytes (HP:0001922) | 2.03166352 |
| 97 | Parakeratosis (HP:0001036) | 2.02564592 |
| 98 | Dicarboxylic aciduria (HP:0003215) | 2.02324327 |
| 99 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02324327 |
| 100 | Reduced antithrombin III activity (HP:0001976) | 1.99856036 |
| 101 | Hypergonadotropic hypogonadism (HP:0000815) | 1.99235780 |
| 102 | Abnormality of the ileum (HP:0001549) | 1.99106455 |
| 103 | Triphalangeal thumb (HP:0001199) | 1.98196008 |
| 104 | Cleft eyelid (HP:0000625) | 1.95924360 |
| 105 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.95830100 |
| 106 | Lethargy (HP:0001254) | 1.95512867 |
| 107 | Abnormality of chromosome stability (HP:0003220) | 1.94114355 |
| 108 | Hypobetalipoproteinemia (HP:0003563) | 1.93919365 |
| 109 | Pancytopenia (HP:0001876) | 1.93716759 |
| 110 | Stenosis of the external auditory canal (HP:0000402) | 1.93671574 |
| 111 | Trismus (HP:0000211) | 1.92970937 |
| 112 | Abnormal lung lobation (HP:0002101) | 1.92133099 |
| 113 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.92104979 |
| 114 | Premature graying of hair (HP:0002216) | 1.91743269 |
| 115 | Hyperammonemia (HP:0001987) | 1.91694731 |
| 116 | Glycosuria (HP:0003076) | 1.89614699 |
| 117 | Abnormality of urine glucose concentration (HP:0011016) | 1.89614699 |
| 118 | Increased muscle lipid content (HP:0009058) | 1.88975250 |
| 119 | Blindness (HP:0000618) | 1.88704289 |
| 120 | Methylmalonic aciduria (HP:0012120) | 1.87972645 |
| 121 | Hypertensive crisis (HP:0100735) | 1.87448196 |
| 122 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.86892590 |
| 123 | Petechiae (HP:0000967) | 1.86759335 |
| 124 | Redundant skin (HP:0001582) | 1.86759146 |
| 125 | Premature ovarian failure (HP:0008209) | 1.84963198 |
| 126 | Posterior subcapsular cataract (HP:0007787) | 1.83913318 |
| 127 | Cutaneous melanoma (HP:0012056) | 1.82980761 |
| 128 | Thrombocytosis (HP:0001894) | 1.82408214 |
| 129 | Abnormal hemoglobin (HP:0011902) | 1.82272443 |
| 130 | Abnormality of reticulocytes (HP:0004312) | 1.81263016 |
| 131 | Bone marrow hypocellularity (HP:0005528) | 1.80254890 |
| 132 | Colon cancer (HP:0003003) | 1.80015799 |
| 133 | Abnormality of renal resorption (HP:0011038) | 1.79990930 |
| 134 | Cutaneous photosensitivity (HP:0000992) | 1.79984227 |
| 135 | Resting tremor (HP:0002322) | 1.79354747 |
| 136 | Optic disc pallor (HP:0000543) | 1.79292191 |
| 137 | Recurrent abscess formation (HP:0002722) | 1.78769164 |
| 138 | Paralysis (HP:0003470) | 1.77973982 |
| 139 | Progressive external ophthalmoplegia (HP:0000590) | 1.77737267 |
| 140 | Entropion (HP:0000621) | 1.77688761 |
| 141 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.77154068 |
| 142 | Congenital, generalized hypertrichosis (HP:0004540) | 1.76440640 |
| 143 | Recurrent bacterial skin infections (HP:0005406) | 1.75418579 |
| 144 | Methylmalonic acidemia (HP:0002912) | 1.75332932 |
| 145 | CNS hypomyelination (HP:0003429) | 1.72424195 |
| 146 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.72369261 |
| 147 | Sparse eyelashes (HP:0000653) | 1.70945344 |
| 148 | Dyschromatopsia (HP:0007641) | 1.70925287 |
| 149 | Hamartoma of the eye (HP:0010568) | 1.70126479 |
| 150 | Autoamputation (HP:0001218) | 1.69409714 |
| 151 | Delusions (HP:0000746) | 1.69156345 |
| 152 | Tetraplegia (HP:0002445) | 1.68877235 |
| 153 | X-linked dominant inheritance (HP:0001423) | 1.67368986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.48993462 |
| 2 | NME2 | 3.78663340 |
| 3 | EIF2AK1 | 3.64358582 |
| 4 | STK16 | 3.46141566 |
| 5 | WEE1 | 3.34330126 |
| 6 | SRPK1 | 3.04813476 |
| 7 | MAPKAPK3 | 2.83297040 |
| 8 | MAP4K2 | 2.60811622 |
| 9 | EIF2AK3 | 2.45796310 |
| 10 | PDK2 | 2.45588041 |
| 11 | TLK1 | 2.21131050 |
| 12 | PIM2 | 2.14331585 |
| 13 | TSSK6 | 2.12318464 |
| 14 | TESK2 | 2.12277439 |
| 15 | PBK | 2.07032312 |
| 16 | PLK4 | 2.01984815 |
| 17 | MAP3K3 | 2.01805011 |
| 18 | VRK1 | 1.99982072 |
| 19 | NME1 | 1.89083725 |
| 20 | IRAK4 | 1.84143728 |
| 21 | CDC7 | 1.83534528 |
| 22 | BRSK2 | 1.72145508 |
| 23 | CSNK1A1L | 1.69980457 |
| 24 | MST4 | 1.67666669 |
| 25 | MAP3K5 | 1.66472607 |
| 26 | PASK | 1.65650167 |
| 27 | ACVR1B | 1.64887922 |
| 28 | VRK2 | 1.56350905 |
| 29 | TAOK1 | 1.51825883 |
| 30 | BLK | 1.47752700 |
| 31 | PLK1 | 1.42863552 |
| 32 | CSNK1G1 | 1.42285169 |
| 33 | DYRK3 | 1.40040941 |
| 34 | MKNK1 | 1.39100667 |
| 35 | MAP2K3 | 1.38682192 |
| 36 | IRAK3 | 1.38342493 |
| 37 | CSNK1G2 | 1.34654449 |
| 38 | TTK | 1.28998236 |
| 39 | TESK1 | 1.27367995 |
| 40 | NEK2 | 1.27159220 |
| 41 | DYRK2 | 1.25747079 |
| 42 | AURKB | 1.21364624 |
| 43 | TIE1 | 1.20382424 |
| 44 | ZAK | 1.20331046 |
| 45 | NEK9 | 1.19776679 |
| 46 | MATK | 1.18584783 |
| 47 | BRAF | 1.18383606 |
| 48 | CCNB1 | 1.15361244 |
| 49 | AURKA | 1.14746408 |
| 50 | DAPK1 | 1.14019914 |
| 51 | EIF2AK2 | 1.12608359 |
| 52 | LIMK1 | 1.12317945 |
| 53 | PLK3 | 1.11114081 |
| 54 | NTRK1 | 1.10686648 |
| 55 | BCKDK | 1.09648830 |
| 56 | BCR | 1.09416824 |
| 57 | KDR | 1.05339571 |
| 58 | BRSK1 | 1.01557635 |
| 59 | FES | 1.01383473 |
| 60 | CDK7 | 1.00127585 |
| 61 | TRIM28 | 0.97578446 |
| 62 | EPHA2 | 0.93950528 |
| 63 | MAP4K1 | 0.93633356 |
| 64 | ATR | 0.91795403 |
| 65 | ABL2 | 0.90299930 |
| 66 | NUAK1 | 0.90069335 |
| 67 | MAP3K1 | 0.88777387 |
| 68 | PLK2 | 0.88309327 |
| 69 | PINK1 | 0.83152895 |
| 70 | MKNK2 | 0.82827660 |
| 71 | TEC | 0.81907427 |
| 72 | TXK | 0.80931390 |
| 73 | RPS6KA4 | 0.78889906 |
| 74 | PIM1 | 0.78246931 |
| 75 | CSNK2A1 | 0.78181821 |
| 76 | RAF1 | 0.75670993 |
| 77 | ZAP70 | 0.74973378 |
| 78 | CDK8 | 0.74649081 |
| 79 | ALK | 0.74359390 |
| 80 | ARAF | 0.73223003 |
| 81 | NLK | 0.71830389 |
| 82 | FER | 0.71446304 |
| 83 | TBK1 | 0.71206162 |
| 84 | NEK1 | 0.70250176 |
| 85 | FRK | 0.69735289 |
| 86 | ERN1 | 0.69038779 |
| 87 | MAP3K8 | 0.67870068 |
| 88 | MAP3K11 | 0.67723117 |
| 89 | CSNK2A2 | 0.67654588 |
| 90 | PAK4 | 0.67423012 |
| 91 | STK4 | 0.63935022 |
| 92 | RPS6KA5 | 0.63429985 |
| 93 | SCYL2 | 0.62630553 |
| 94 | TGFBR1 | 0.62070315 |
| 95 | MARK3 | 0.61503754 |
| 96 | SIK3 | 0.61282716 |
| 97 | PRKCI | 0.61220602 |
| 98 | LMTK2 | 0.59595283 |
| 99 | CHEK2 | 0.59513692 |
| 100 | TYK2 | 0.59451751 |
| 101 | RPS6KB2 | 0.59365835 |
| 102 | PAK1 | 0.59341511 |
| 103 | LRRK2 | 0.58185557 |
| 104 | MAP2K7 | 0.57460358 |
| 105 | IRAK2 | 0.57400195 |
| 106 | EPHA3 | 0.56084981 |
| 107 | IRAK1 | 0.55616066 |
| 108 | IKBKB | 0.55376841 |
| 109 | STK38L | 0.55305212 |
| 110 | MAPKAPK2 | 0.52927305 |
| 111 | DAPK3 | 0.52570123 |
| 112 | YES1 | 0.51653290 |
| 113 | ILK | 0.50937162 |
| 114 | CDK4 | 0.50818779 |
| 115 | ADRBK2 | 0.49804117 |
| 116 | MYLK | 0.48791958 |
| 117 | CHEK1 | 0.48145117 |
| 118 | IKBKE | 0.47954659 |
| 119 | MAP3K10 | 0.47215891 |
| 120 | STK24 | 0.46426629 |
| 121 | MOS | 0.44603832 |
| 122 | TAOK2 | 0.43849974 |
| 123 | MAP3K14 | 0.41358406 |
| 124 | PRKG2 | 0.41034124 |
| 125 | BMPR2 | 0.40988927 |
| 126 | LYN | 0.39981353 |
| 127 | CSNK1G3 | 0.38253980 |
| 128 | WNK4 | 0.37554437 |
| 129 | PRKD2 | 0.37146347 |
| 130 | OBSCN | 0.35438630 |
| 131 | CLK1 | 0.34023904 |
| 132 | GRK7 | 0.33435206 |
| 133 | BTK | 0.33401260 |
| 134 | ATM | 0.32377217 |
| 135 | MAP2K6 | 0.32314384 |
| 136 | MAP3K12 | 0.32134513 |
| 137 | GRK1 | 0.31999727 |
| 138 | SYK | 0.31937784 |
| 139 | STK10 | 0.31775650 |
| 140 | GRK6 | 0.30941545 |
| 141 | CDK2 | 0.30728816 |
| 142 | MST1R | 0.30623024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.96760479 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.54244637 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.68722139 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.67536829 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.14272598 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.72692589 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.64957044 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.59149491 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.40658664 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.36965513 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.34002455 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.31527093 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.30165310 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.22829258 |
| 15 | RNA transport_Homo sapiens_hsa03013 | 2.15271408 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 2.14933707 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.88816803 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 1.76693200 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.72307727 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.66633773 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.65825634 |
| 22 | Cell cycle_Homo sapiens_hsa04110 | 1.47190072 |
| 23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.45938658 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42397180 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.35828622 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.32328050 |
| 27 | Purine metabolism_Homo sapiens_hsa00230 | 1.31175827 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.26920136 |
| 29 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.25301682 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.20453843 |
| 31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20067053 |
| 32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.15539313 |
| 33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09518796 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.08634960 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08161284 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08072223 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.06679899 |
| 38 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.04506898 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03247281 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.02342028 |
| 41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02134322 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.01903736 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98230166 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96661715 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93557127 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.93508373 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91944273 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.91146968 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90600937 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88221625 |
| 51 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.86942607 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.85606751 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.80583907 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80231133 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78683622 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77777134 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76629435 |
| 58 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.73525716 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72228794 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.68609243 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67259714 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.66431151 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65762308 |
| 64 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64625664 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 0.63647875 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61092895 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60263159 |
| 68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59855464 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59360160 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59101870 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59053975 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58813908 |
| 73 | * Herpes simplex infection_Homo sapiens_hsa05168 | 0.57565203 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56964140 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56263014 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.53723900 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.51894556 |
| 78 | Allograft rejection_Homo sapiens_hsa05330 | 0.51702720 |
| 79 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51090030 |
| 80 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50554095 |
| 81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.49656301 |
| 82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47503269 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47254307 |
| 84 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.47175953 |
| 85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.46866026 |
| 86 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44727356 |
| 87 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44286657 |
| 88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.43052576 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41659402 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.41590429 |
| 91 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.41433996 |
| 92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41093618 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40855245 |
| 94 | Asthma_Homo sapiens_hsa05310 | 0.40297983 |
| 95 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.39376108 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.39084742 |
| 97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.38840981 |
| 98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38424947 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36691067 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.35866195 |
| 101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35419270 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.35156650 |
| 103 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.34811254 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34222511 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.33916641 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32945546 |
| 107 | Histidine metabolism_Homo sapiens_hsa00340 | 0.32636042 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32442624 |
| 109 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.31518907 |
| 110 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.30956849 |
| 111 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.29484824 |
| 112 | Shigellosis_Homo sapiens_hsa05131 | 0.28780834 |
| 113 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27626260 |
| 114 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.27609212 |
| 115 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27591041 |
| 116 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.27394109 |
| 117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.27034252 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26135288 |
| 119 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25414042 |
| 120 | Apoptosis_Homo sapiens_hsa04210 | 0.24513928 |
| 121 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.24510341 |
| 122 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23520751 |
| 123 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.23167070 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21984458 |
| 125 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.20715748 |
| 126 | Measles_Homo sapiens_hsa05162 | 0.20245547 |

